The anti-malarial chloroquine overcomes Primary resistance and restores sensitivity to Trastuzumab in HER2-positive breast cancer
2013 · Scientific Reports · 119 citations
https://doi.org/10.1038/srep02469
B
Bruna Corominas-Faja
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
41
Papers
2.7K
Citations
31
h-index
38
i10-index
Bruna Corominas-Faja is an academic researcher from Institut Català d'Oncologia. The author has contributed to research in topics: Cancer, Hypoxia, and Metabolism & Metabolism, Diabetes, and Cancer & Epigenetics and DNA Methylation. The author has an h-index of 31, co-authored 35 publications.
Papers by this author
worksChemical inhibition of acetyl-CoA carboxylase suppresses self-renewal growth of cancer stem cells
2014 · Oncotarget · 114 citations
https://doi.org/10.18632/oncotarget.2059
Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo
2013 · Scientific Reports · 75 citations
https://doi.org/10.1038/srep02459
Autophagy-related gene 12 (ATG12) is a novel determinant of primary resistance to HER2-targeted therapies: Utility of transcriptome analysis of the autophagy interactome to guide breast cancer treatment
2012 · Oncotarget · 75 citations
https://doi.org/10.18632/oncotarget.742
Basal/HER2 breast carcinomas
2013 · Cell Cycle · 53 citations
https://doi.org/10.4161/cc.23274
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat